Clinical Trial Update: Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating high-dose calcitriol in combination with temodar for metastatic melanoma has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Calcitriol (calcitriol)
• Temodar (Temozolomide)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-28